BHCM
EVH icon

Boulder Hill Capital Management’s Evolent Health EVH Stock Holding History

Boulder Hill Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,200
Closed -$286K – 162
2022
Q4 		$286K Buy
+10,200
New +$292K 0.24% 94
2022
Q1 		– Sell
-9,900
Closed -$274K – 172
2021
Q4 		$274K Buy
+9,900
New +$284K 0.27% 131

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boulder Hill Capital Management's EVH Position: Q1 2023 in Review

Boulder Hill Capital Management sold out of Evolent Health (EVH) in Q1 2023, closing a stake of 10,200 shares — an estimated $286K sold.

Boulder Hill Capital Management first reported a position in EVH in Q4 2021 and held it in 2 quarters. The position peaked at $286K in Q4 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q1 2023.

  • Boulder Hill Capital Management reported no remaining Evolent Health position as of Q1 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 10,200 Evolent Health shares in Q1 2023, an estimated $286K.
  • Boulder Hill Capital Management first reported a position in Evolent Health in Q4 2021 and held it in 2 quarters.
  • Boulder Hill Capital Management's Evolent Health position peaked at $286K in Q4 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q1 2023.

Based on Boulder Hill Capital Management's 13F filing for Q1 2023, filed 12 May 2023.